Deutsche Bank analyst Emmanuel Papadakis downgraded GSK (GSK) to Hold from Buy with a price target of 1,350 GBp, down from 1,700 GBp.

The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna were roughly 9% ...

U.K. stocks were lower after the close on Friday, as losses in the Pharmaceuticals & Biotech, Media and Food Producers ...

The UK stock market experienced declines with significant impacts from AstraZeneca and GSK, contributing to the FTSE 100's ...

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...

The main UK stock indexes slipped on Friday, with losses in AstraZeneca and GSK weighing on the blue-chip FTSE 100, while data showed Britain's economy contracted unexpectedly in September.

Shares of several of the world’s largest vaccine makers fell Friday, the day after Donald Trump announced he had selected ...

Guggenheim's Inaugural Healthcare Innovation Conference November 12, 2024 2:00 PM ETCompany ParticipantsEmma Walmsley - Chief ...

The awards are presented annually to organizations in the Greater Philadelphia and Triangle (North Carolina) regions.

As head of HHS, Kennedy would lead a sprawling federal department that encompasses more than 100 programs supporting medicine ...

Leading companies in the functional foods market are concentrating on creating innovative products, including new plant-based ingredients, to enhance their market position. Plant ingredients are ...

Global stocks fell after Jerome Powell signalled the Federal Reserve was in no rush to cut interest rates, and unease built ...